Cathelicidin-deficient (Cnlp -/- ) mice show increased susceptibility to Pseudomonas aeruginosa keratitis.

PURPOSE To examine the clinical progression and innate immune responses during Pseudomonas aeruginosa (PA) keratitis in cathelicidin-deficient (KO) mice. METHODS PA (ATCC 19660) keratitis was induced in KO mice and wild-type (WT) littermates generated on a 129/SVJ background. Clinical score and histopathology were used to monitor the progression of infection at postinfection (PI) days 1, 3, 7, 14, and 21. Mouse corneas were harvested for viable bacteria quantitation, and myeloperoxidase (MPO) assays were performed to determine the number of infiltrating neutrophils. ELISA was used to quantitate interleukin (IL)-1beta, IL-6, macrophage inflammatory peptide (MIP)-2, keratinocyte-derived chemokine (KC), tumor necrosis factor (TNF)-alpha, and vascular endothelial growth factor (VEGF) levels in the corneas. RESULTS WT mice were resistant (cornea healed), whereas KO mice showed increased susceptibility (corneas failed to recover by 21 days or perforated) to PA infection. Clinical scores were significantly elevated in the infected corneas of KO mice versus WT mice at 7, 14, and 21 days PI. Absence of cathelicidin resulted in significantly delayed clearance of PA in the cornea and an increased number of infiltrating neutrophils at 1, 3, 7, and 14 days PI. KO mice also exhibited differential expression of protein levels for IL-1beta, IL-6, MIP-2, KC, TNF-alpha, and VEGF up to day 21 PI compared with the WT mice. CONCLUSIONS Cathelicidin-deficient mice showed considerable susceptibility to PA keratitis. The present study demonstrates direct in vivo evidence that endogenous expression of cathelicidin provides defense against corneal PA infection indicating its importance in host innate immunity at the ocular surface.

[1]  A. Di Nardo,et al.  Cathelicidin Antimicrobial Peptides Block Dendritic Cell TLR4 Activation and Allergic Contact Sensitization1 , 2007, The Journal of Immunology.

[2]  C. Vogelmeier,et al.  The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands. , 2006, International immunology.

[3]  L. Hazlett,et al.  TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis. , 2006, Investigative ophthalmology & visual science.

[4]  Ayyalusamy Ramamoorthy,et al.  LL-37, the only human member of the cathelicidin family of antimicrobial peptides. , 2006, Biochimica et biophysica acta.

[5]  A. Scheynius,et al.  Antimicrobial Peptide LL‐37 Internalized by Immature Human Dendritic Cells Alters their Phenotype , 2006, Scandinavian journal of immunology.

[6]  T. Hökfelt,et al.  The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection , 2006, Nature Medicine.

[7]  Ling C. Huang,et al.  Multifunctional roles of human cathelicidin (LL-37) at the ocular surface. , 2006, Investigative ophthalmology & visual science.

[8]  M. Flaig,et al.  Cathelicidin deficiency predisposes to eczema herpeticum. , 2006, The Journal of allergy and clinical immunology.

[9]  B. Rouse,et al.  Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. , 2006, Experimental eye research.

[10]  H. Tanihara,et al.  Role of Cytokines and Chemokines in Pseudomonal Keratitis , 2005, Cornea.

[11]  T. Hisatomi,et al.  Cellular Events in the Normal and Inflamed Cornea , 2005, Cornea.

[12]  V. Nizet,et al.  Keratinocyte Production of Cathelicidin Provides Direct Activity against Bacterial Skin Pathogens , 2005, Infection and Immunity.

[13]  W. Shafer,et al.  Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages , 2005, Cellular microbiology.

[14]  S. Kunkel,et al.  Neutrophil-derived cytokines: potential therapeutic targets in inflammation. , 2005, Current drug targets. Inflammation and allergy.

[15]  F. Yarovinsky,et al.  Mouse Cathelin-Related Antimicrobial Peptide Chemoattracts Leukocytes Using Formyl Peptide Receptor-Like 1/Mouse Formyl Peptide Receptor-Like 2 as the Receptor and Acts as an Immune Adjuvant1 , 2005, The Journal of Immunology.

[16]  Ling C. Huang,et al.  Human Cathelicidin (LL-37), a Multifunctional Peptide, is Expressed by Ocular Surface Epithelia and has Potent Antibacterial and Antiviral Activity , 2005, Current eye research.

[17]  J. Treat,et al.  Antimicrobial peptides: effectors of innate immunity in the skin. , 2005, Advances in dermatology.

[18]  R. Hancock,et al.  The Human Cationic Peptide LL-37 Induces Activation of the Extracellular Signal-Regulated Kinase and p38 Kinase Pathways in Primary Human Monocytes1 , 2004, The Journal of Immunology.

[19]  B. Finlay,et al.  Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  James F. Jones,et al.  Selective Killing of Vaccinia Virus by LL-37: Implications for Eczema Vaccinatum1 , 2004, The Journal of Immunology.

[21]  L. Hazlett.  Corneal response to Pseudomonas aeruginosa infection , 2004, Progress in Retinal and Eye Research.

[22]  Robert E. W. Hancock,et al.  The Cationic Antimicrobial Peptide LL-37 Modulates Dendritic Cell Differentiation and Dendritic Cell-Induced T Cell Polarization1 , 2004, The Journal of Immunology.

[23]  M. Kagnoff,et al.  Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori. , 2003, Gastroenterology.

[24]  E. K. Mela,et al.  Ulcerative Keratitis in Contact Lens Wearers , 2003, Eye & contact lens.

[25]  A. McDermott,et al.  Expression of human β-defensins in conjunctival epithelium : relevance to dry eye disease , 2003 .

[26]  L. Hazlett,et al.  Analysis of Pseudomonas aeruginosa corneal infection using an oligonucleotide microarray. , 2003, Investigative ophthalmology & visual science.

[27]  S. Zahler,et al.  An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. , 2003, The Journal of clinical investigation.

[28]  L. Laroche,et al.  Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases , 2003, The British journal of ophthalmology.

[29]  Ling C. Huang,et al.  Defensin expression by the cornea: multiple signalling pathways mediate IL-1beta stimulation of hBD-2 expression by human corneal epithelial cells. , 2003, Investigative ophthalmology & visual science.

[30]  R. Gallo,et al.  Neonatal Skin in Mice and Humans Expresses Increased Levels of Antimicrobial Peptides: Innate Immunity During Development of the Adaptive Response , 2003, Pediatric Research.

[31]  A. Husband,et al.  Experimental Pseudomonas aeruginosa Keratitis in Interleukin-10 Gene Knockout Mice , 2003, Infection and Immunity.

[32]  A. Husband,et al.  Pseudomonas aeruginosa Keratitis in IL-6-Deficient Mice , 2003, International Archives of Allergy and Immunology.

[33]  C. Ciornei,et al.  Effects of human cathelicidin antimicrobial peptide LL‐37 on lipopolysaccharide‐induced nitric oxide release from rat aorta in vitro , 2003, Acta anaesthesiologica Scandinavica.

[34]  A. McDermott,et al.  Expression of human beta-defensins in conjunctival epithelium: relevance to dry eye disease. , 2003, Investigative ophthalmology & visual science.

[35]  T. Ohtake,et al.  Cathelicidin Antimicrobial Peptides are Expressed in Salivary Glands and Saliva , 2002, Journal of dental research.

[36]  I. Nagaoka,et al.  Augmentation of the Lipopolysaccharide-Neutralizing Activities of Human Cathelicidin CAP18/LL-37-Derived Antimicrobial Peptides by Replacement with Hydrophobic and Cationic Amino Acid Residues , 2002, Clinical and Vaccine Immunology.

[37]  David J. Evans,et al.  The pathogenesis of bacterial keratitis: studies with Pseudomonas aeruginosa , 2002, Clinical & experimental optometry.

[38]  M. Willcox,et al.  Macrophage inflammatory protein‐2 and vascular endothelial growth factor regulate corneal neovascularization induced by infection with Pseudomonas aeruginosa in mice , 2002, Immunology and cell biology.

[39]  R. Gallo,et al.  Cathelicidins, essential gene-encoded mammalian antibiotics , 2002, Journal of Molecular Medicine.

[40]  M. Willcox,et al.  Gene expression of pro‐inflammatory cytokines and chemokines in mouse eye infected with Pseudomonas aeruginosa , 2002, Clinical & experimental ophthalmology.

[41]  L. Hazlett.  Pathogenic mechanisms of P. aeruginosa keratitis: a review of the role of T cells, Langerhans cells, PMN, and cytokines. , 2002, DNA and cell biology.

[42]  K. Iwabuchi,et al.  A cathelicidin family of human antibacterial peptide LL‐37 induces mast cell chemotaxis , 2002, Immunology.

[43]  D. Wakefield,et al.  Balance of Pro- and Anti-Inflammatory Cytokines Correlates with Outcome of Acute Experimental Pseudomonas aeruginosa Keratitis , 2002, Infection and Immunity.

[44]  R. Gennaro,et al.  Cathelicidin peptides as candidates for a novel class of antimicrobials. , 2002, Current pharmaceutical design.

[45]  Takaaki Ohtake,et al.  Innate antimicrobial peptide protects the skin from invasive bacterial infection , 2001, Nature.

[46]  Kenneth Huttner,et al.  Processing site and gene structure for the murine antimicrobial peptide CRAMP , 2001, Peptides.

[47]  V. Nizet,et al.  Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. , 2001, The Journal of investigative dermatology.

[48]  R. Redfern,et al.  Human ß-defensin 2 is up-regulated during re-epithelialization of the cornea , 2001 .

[49]  A. Kijlstra,et al.  The role of cytokines in corneal immunopathology , 2001, Ocular immunology and inflammation.

[50]  D. Azar,et al.  Corneal neovascularization. , 2001, Current opinion in ophthalmology.

[51]  A. Risso.  Leukocyte antimicrobial peptides: multifunctional effector molecules of innate immunity , 2000, Journal of leukocyte biology.

[52]  Ji Ming Wang,et al.  Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells , 2000, The Journal of experimental medicine.

[53]  L. Hazlett,et al.  Prolonged Elevation of IL-1 in Pseudomonas aeruginosa Ocular Infection Regulates Macrophage-Inflammatory Protein-2 Production, Polymorphonuclear Neutrophil Persistence, and Corneal Perforation1 , 2000, The Journal of Immunology.

[54]  L. Hazlett,et al.  Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive. , 2000, Investigative ophthalmology & visual science.

[55]  J. A. Hobden,et al.  Macrophage Inflammatory Protein-2 Is a Mediator of Polymorphonuclear Neutrophil Influx in Ocular Bacterial Infection1 , 2000, The Journal of Immunology.

[56]  A. Husband,et al.  KC production in the cornea in response to Pseudomonas aeruginosa challenge , 1999, Immunology and cell biology.

[57]  R. Gennaro,et al.  Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. , 2000, Biopolymers.

[58]  James M. Wilson,et al.  Augmentation of Innate Host Defense by Expression of a Cathelicidin Antimicrobial Peptide , 1999, Infection and Immunity.

[59]  A. Husband,et al.  Expression of Interleukin-6 in the Cornea in Response to Infection with Different Strains of Pseudomonas aeruginosa , 1999, Infection and Immunity.

[60]  R. Bals,et al.  Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. , 1999, The Journal of clinical investigation.

[61]  A. Husband,et al.  TNF‐α production in the cornea in response to Pseudomonas aeruginosa challenge , 1999, Immunology and cell biology.

[62]  J. A. Hobden,et al.  Pseudomonas aeruginosa Keratitis in Knockout Mice Deficient in Intercellular Adhesion Molecule 1 , 1999, Infection and Immunity.

[63]  B. Rouse,et al.  Production of key molecules by ocular neutrophils early after herpetic infection of the cornea. , 1998, Experimental eye research.

[64]  T. Tumpey,et al.  Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea. , 1998, Investigative ophthalmology & visual science.

[65]  R. Bals,et al.  The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[66]  A. Husband,et al.  Different strains of Pseudomonas aeruginosa isolated from ocular infections or inflammation display distinct corneal pathologies in an animal model. , 1998, Current eye research.

[67]  L. Hazlett,et al.  Corneal Infection in Mice Pseudomonas Aeruginosa Expression During , 1998 .

[68]  C. Kozak,et al.  Identification of CRAMP, a Cathelin-related Antimicrobial Peptide Expressed in the Embryonic and Adult Mouse* , 1997, The Journal of Biological Chemistry.

[69]  L. Hazlett,et al.  In vivo characterization of host and bacterial protease expression during Pseudomonas aeruginosa corneal infections in naive and immunized mice. , 1997, Current eye research.

[70]  J. Odeberg,et al.  The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. , 1996, European journal of biochemistry.

[71]  J. A. Hobden,et al.  Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence. , 1996, Investigative ophthalmology & visual science.

[72]  Domenico Romeo,et al.  Cathelicidins: a novel protein family with a common proregion and a variable C‐terminal antimicrobial domain , 1995, FEBS letters.

[73]  W. Wood,et al.  Chemokine binding and activities mediated by the mouse IL-8 receptor. , 1995, Journal of immunology.

[74]  A. Johnsen,et al.  hCAP‐18, a cathelin/pro‐bactenecin‐like protein of human neutrophil specific granules , 1995, FEBS letters.

[75]  J. A. Hobden,et al.  Aged mice fail to upregulate ICAM-1 after Pseudomonas aeruginosa corneal infection. , 1995, Investigative ophthalmology & visual science.

[76]  Melinda Fitzgerald,et al.  Immunol. Cell Biol. , 1995 .

[77]  K. Driscoll.  Macrophage inflammatory proteins: biology and role in pulmonary inflammation. , 1994, Experimental lung research.

[78]  R. Strieter,et al.  Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.

[79]  S. Akira,et al.  Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF) , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[80]  W. Risau,et al.  Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[81]  C. Paterson,et al.  Quantification of ocular inflammation: evaluation of polymorphonuclear leucocyte infiltration by measuring myeloperoxidase activity. , 1982, Current eye research.